Bersanlimab

Tax included
Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects.
HY-P99473

Data sheet

Size
Multiple sizes
Reactivity
Integrin
CAS
1987854-08-9